Literature DB >> 32384072

Prevalence, survival and subsequent fertility of dairy and beef cows with uterine prolapse.

Augusto Carluccio1, Ippolito De Amicis1, Monica Probo2, Brunella Giangaspero1, Maria Cristina Veronesi2.   

Abstract

The aim of this study was to evaluate the prevalence of uterine prolapse in cows and assess its effects on survival and subsequent fertility. Of 33,450 calving cows considered retrospectively, 216 (0.6%) developed uterine prolapse. A higher prevalence was found in beef cows (n = 57/5,700 cows, 1%) compared to dairy cows (n = 157/27,750 cows, 0.6%). Treatment consisted of cleaning and replacing the uterus with local administration of antibiotics, and applying a harness for uterine containment. The recovery rate was 81.9% (n = 177), similar in dairy (n = 129; 81.1%) and beef (n = 48; 84.2%) cows. Of the 216 cows with uterine prolapse, 18 (8.3%) died before or immediately after treatment; 21 cows (9.7%) were voluntarily culled for economic reasons (low milk yield, low fertility, insufficient weight gain). All recovered dairy cows were artificially inseminated with semen of proven fertility after a voluntary waiting period of 50 days; the beef cows were naturally mated. Among the 172 inseminated/mated cows, 84.7% (n = 150) became pregnant (83.7% dairy cows, 87.5% beef cows), while 15.2% (n = 27) did not conceive. Recurrence of uterine prolapse at subsequent calvings was recorded in one dairy cow. Based upon the data presented here, treated cows with uterine prolapse showed high chances of survival and conception, and a low risk of recurrence.

Entities:  

Keywords:  cattle; fertility; prevalence; survival; uterine prolapse

Mesh:

Year:  2020        PMID: 32384072     DOI: 10.1556/004.2020.00017

Source DB:  PubMed          Journal:  Acta Vet Hung        ISSN: 0236-6290            Impact factor:   0.955


  1 in total

1.  Vaginal microbiome and serum metabolite differences in late gestation commercial sows at risk for pelvic organ prolapse.

Authors:  Zoë E Kiefer; Lucas R Koester; Lucas Showman; Jamie M Studer; Amanda L Chipman; Aileen F Keating; Stephan Schmitz-Esser; Jason W Ross
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.